RYALTRIS
RYALTRIS
Approved
DIN Number
02531186
Drug Class
Human
Market Date
Mar 17, 2023
Company
HC
Glenmark Specialty SA
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02531186
AIG Number0264081001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R01AD59 MOMETASONE, COMBINATIONS
Product Specifications
Dosage FormSpray, Metered Dose
Route of AdministrationNasal
AHFS Classification52:08.08
Health Canada Classification
ACTIVE INGREDIENTS (2)
MOMETASONE FUROATE (MOMETASONE FUROATE MONOHYDRATE)Active
Strength: 25 MCG / ACT
Monograph: MOMETASONE FUROATE (MOMETASONE FUROATE MONOHYDRATE)
OLOPATADINE HYDROCHLORIDEActive
Strength: 665 MCG / ACT
Monograph: OLOPATADINE HYDROCHLORIDE